De Novo Immunoglobulin A Vasculitis Following Exposure to SARS-CoV-2 Immunization

REFERENCES

1. 1.↵
   1. Shimmel A,
   2. Shaikhouni S,
   3. Mariani L

   . Current understanding of clinical manifestations of COVID-19 in glomerular disease. Glomerular Dis. 2021;1(4):250-264. doi: 10.1159/000518276

   OpenUrlCrossRef
2. 2.↵
   1. Wu H,
   2. Larsen CP,
   3. Hernandez-Arroyo CF,
   4. et al.

   AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype. J Am Soc Nephrol. 2020;31(8):1688-1695. doi: 10.1681/ASN.2020050558

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Bomback AS,
   2. Kudose S,
   3. D'Agati VD

   . De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far? Am J Kidney Dis. 2021;78(4):477-480. doi: 10.1053/j.ajkd.2021.06.004

   OpenUrlCrossRef
4. 4.↵
   1. Sacker A,
   2. Kung V,
   3. Andeen N

   . Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination. Kidney Int. 2021;100(2):471-472. doi: 10.1016/j.kint.2021.06.006

   OpenUrlCrossRef
5. 5.↵
   1. Gutiérrez S,
   2. Dotto B,
   3. Petiti JP,
   4. et al.

   Minimal change disease following influenza vaccination and acute renal failure: just a coincidence? Nefrologia. 2012;32(3):414-415. doi: 10.3265/Nefrologia.pre2012.Feb.11370

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Kikuchi Y,
   2. Imakiire T,
   3. Hyodo T,
   4. et al.

   Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccine. Clin Nephrol. 2002;58(1):68-72. doi: 10.5414/cnp58068

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Patel C,
   2. Shah HH

   . Membranous nephropathy and severe acute kidney injury following influenza vaccination. Saudi J Kidney Dis Transpl. 2015;26(6):1289-1293. doi: 10.4103/1319-2442.168676

   OpenUrlCrossRef
8. 8.↵
   1. Rahim SEG,
   2. Lin JT,
   3. Wang JC

   . A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney Int. 2021;100(1):238. doi: 10.1016/j.kint.2021.04.024

   OpenUrlCrossRef
9. 9.
   1. Negrea L,
   2. Rovin BH

   . Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney Int. 2021;99(6):1487. doi: 10.1016/j.kint.2021.03.002

   OpenUrlCrossRef
10. 10.
    1. Perrin P,
    2. Bassand X,
    3. Benotmane I,
    4. Bouvier N

    . Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy. Kidney Int. 2021;100(2):466-468. doi: 10.1016/j.kint.2021.05.022

    OpenUrlCrossRef
11. 11.↵
    1. Horino T

    . IgA nephropathy flare-up following SARS-CoV-2 vaccination. QJM. 2021:hcab223. doi: 10.1093/qjmed/hcab223

    OpenUrlCrossRef
12. 12.↵
    1. de Wolf ACMT,
    2. van Aalst S,
    3. Ludwig IS,
    4. et al.

    Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS One. 2017;12(6):e0179942. doi: 10.1371/journal.pone.0179942

    OpenUrlCrossRef
13. 13.↵
    1. Shalhoub RJ

    . Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;304(7880):556-560. doi: 10.1016/s0140-6736(74)91880-7

    OpenUrlCrossRef
14. 14.↵
    1. Kielstein JT,
    2. Termühlen L,
    3. Sohn J,
    4. Kliem V

    . Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol. 2000;54(3):246-248.

    OpenUrlPubMed
15. 15.
    1. Lebedev L,
    2. Sapojnikov M,
    3. Wechsler A,
    4. et al.

    Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78(1):142-145. doi: 10.1053/j.ajkd.2021.03.010

    OpenUrlCrossRef
16. 16.
    1. Clajus C,
    2. Spiegel J,
    3. Bröcker V,
    4. Chatzikyrkou C,
    5. Kielstein JT

    . Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination. BMC Nephrol. 2009;10:21. doi: 10.1186/1471-2369-10-21

    OpenUrlCrossRefPubMed
17. 17.
    1. Humphreys BD,
    2. Vanguri VK,
    3. Henderson J,
    4. Antin JH

    . Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient. Nat Clin Pract Nephrol. 2006;2(9):535-539; quiz 540. doi: 10.1038/ncpneph0271

    OpenUrlCrossRefPubMedWeb of Science
18. 18.
    1. Işlek I,
    2. Cengiz K,
    3. Cakir M,
    4. Küçüködük S

    . Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol. 2000;14(1):89-90.

    OpenUrlPubMed
19. 19.↵
    1. Ozdemir S,
    2. Bakkaloğlu A,
    3. Oran O

    . Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association? Nephrol Dial Transplant. 1998;13(7):1888-1889. doi: 10.1093/oxfordjournals.ndt.a027900

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Abramson M,
    2. Mon-Wei Yu S,
    3. Campbell KN,
    4. Chung M,
    5. Salem F

    . IgA nephropathy after SARS-CoV-2 vaccination. Kidney Med. 2021;3(5):860-863. doi: 10.1016/j.xkme.2021.05.002

    OpenUrlCrossRef
21. 21.↵
    1. Anderegg MA,
    2. Liu M,
    3. Saganas C,
    4. et al.

    De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int. 2021;100(2):474-476. doi: 10.1016/j.kint.2021.05.016

    OpenUrlCrossRef
22. 22.↵
    1. Naranjo CA,
    2. Busto U,
    3. Sellers EM,
    4. et al.

    A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi: 10.1038/clpt.1981.154

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Da Dalt L,
    2. Zerbinati C,
    3. Strafella MS

    , et al; Italian Multicenter Study Group for Drug and Vaccine Safety in Children. Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study. Ital J Pediatr. 2016;42(1):60. doi: 10.1186/s13052-016-0267-2

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Bonetto C,
    2. Trotta F,
    3. Felicetti P

    , et al; Brighton Collaboration Vasculitis Working Group. Vasculitis as an adverse event following immunization - systematic literature review. Vaccine. 2016;34(51):6641-6651. doi: 10.1016/j.vaccine.2015.09.026

    OpenUrlCrossRef
25. 25.↵
    1. McMahon DE,
    2. Amerson E,
    3. Rosenbach M,
    4. et al.

    Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092

    OpenUrlCrossRef
26. 26.↵
    1. Hines AM,
    2. Murphy N,
    3. Mullin C,
    4. Barillas J,
    5. Barrientos JC.

    Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. 2021;39(33):4571-4572. doi: 10.1016/j.vaccine.2021.06.079

    OpenUrlCrossRef
27. 27.↵
    1. Gillion V,
    2. Jadoul M,
    3. Demoulin N,
    4. Aydin S,
    5. Devresse A

    . Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine. Kidney Int. 2021;100(3):706-707. doi: 10.1016/j.kint.2021.06.033

    OpenUrlCrossRef
28. 28.↵
    1. Johnson EF,
    2. Wetter DA,
    3. Lehman JS,
    4. Hand JL,
    5. Davis DMR,
    6. Tollefson MM

    . Leukocytoclastic vasculitis in children: clinical characteristics, subtypes, causes and direct immunofluorescence findings of 56 biopsy-confirmed cases. J Eur Acad Dermatol Venereol. 2017;31(3):544-549. doi: 10.1111/jdv.13952

    OpenUrlCrossRefPubMed